Filing Details

Accession Number:
0001209191-19-015617
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-04 16:24:31
Reporting Period:
2019-02-28
Accepted Time:
2019-03-04 16:24:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1427925 Acelrx Pharmaceuticals Inc ACRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1511368 G Lawrence Hamel C/O Acelrx Pharmaceuticals, Inc.
351 Galveston Drive
Redwood City CA 94063
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-28 3,682 $2.81 78,053 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 29,795 Indirect By the Hamel Revocable Living Trust
Footnotes
  1. Balance includes non-reportable acquisition of 3,682 shares of Common Stock through the Company's Employee Stock Purchase Plan.